Adverse drug events in patients hospitalized in internal medicine

被引:10
|
作者
Zapatero Gaviria, A. [2 ]
Barba, R. [1 ]
Ruiz Giardin, J. M. [2 ]
Losa Garcia, J. Emilio [3 ]
Marco Martinez, J. [4 ]
Plaza Canteli, S. [5 ]
Canora Lebrato, J. [2 ]
机构
[1] Hosp Infanta Cristina, Madrid, Spain
[2] Hosp Univ Fuenlabrada, Madrid, Spain
[3] Hosp Univ Fdn Alcorcon, Madrid, Spain
[4] Hosp Clin San Carlos, Madrid, Spain
[5] Hosp Severo Ochoa, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2010年 / 210卷 / 06期
关键词
Adverse drug events; Adverse drug reactions; Medication error; Internal Medicine; ELDERLY-PATIENTS; MEDICATION;
D O I
10.1016/j.rce.2009.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Adverse drug events (ADE) are a public health problem, the dimension of which is difficult to quantify because it is under-reported. We have aimed to identify and describe the ADEs recorded in the minimum basic data set (MBDS) of the Internal Medicine Services during the years 2005-7. Patients and methods: A cross-sectional study. Those episodes coded as such, according to the ICD-9-CM, in the discharge reports of all the patients hospitalized during 2005-07 in the entire Spanish territory, were selected. The sociodemographic variables, diagnostic categories and types of drugs, among others, were described and analyzed. Results: Of the 1,567,659 discharges coded in the Minimum Basic Data Set" (MBDS), 96,607 ADEs were recorded in 86,880 episodes (5.55%). Of these 82.86% were not preventable and 17.14% were preventable. A total of 4.5% of the episodes recorded an adverse drug reaction (ADR). The ADE's were more frequent in women and the appearance of an ADR during admission was accompanied by an increase in the hospital stay. Conclusions: The MBDS is a useful tool for the identification, quantification and analysis of the ADRs, however, it is limited by the low recording of the discharge reports. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 50 条
  • [1] Adverse drug events in internal medicine
    Sanchez-Munoz, L. A.
    Mayor-Toranzo, E.
    Alarcon-Garzon, I.
    Nogales-Martin, L.
    [J]. REVISTA CLINICA ESPANOLA, 2010, 210 (10): : 532 - 533
  • [2] Adverse drug events in hospitalized patients
    Raschetti, R
    MennitiIppolito, F
    Morgutti, M
    Belisari, A
    Rossignoli, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17): : 1351 - 1352
  • [3] Preventable adverse drug events in hospitalized patients
    Otero-López, MJ
    Alonso-Hernández, P
    Maderuelo-Fernández, JA
    Garrido-Corro, B
    Domínguez-Gil, A
    Sánchez-Rodríguez, A
    [J]. MEDICINA CLINICA, 2006, 126 (03): : 81 - 87
  • [4] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [5] Adverse drug events in hospitalized patients - Reply
    Bates, DW
    Cullen, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17): : 1353 - 1354
  • [6] Adverse drug events in hospitalized cardiac patients
    Fanikos, John
    Cina, Jennifer L.
    Baroletti, Steven
    Fiumara, Karen
    Matta, Lina
    Goldhaber, Samuel Z.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09): : 1465 - 1469
  • [7] PREVENTING ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS
    EVANS, RS
    PESTOTNIK, SL
    CLASSEN, DC
    HORN, SD
    BASS, SB
    BURKE, JP
    [J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (04) : 523 - 527
  • [8] Adverse drug events in hospitalized elderly
    Gray, SL
    Sager, M
    Lestico, MR
    Jalaluddin, M
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1998, 53 (01): : M59 - M63
  • [9] Recognition of adverse drug events in older hospitalized medical patients
    Joanna E. Klopotowska
    Peter C. Wierenga
    Susanne M. Smorenburg
    Clementine C. M. Stuijt
    Lambertus Arisz
    Paul F. M. Kuks
    Marcel G. W. Dijkgraaf
    Loraine Lie-A-Huen
    Sophia E. de Rooij
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 75 - 85
  • [10] Adverse drug events in hospitalized patients with chronic kidney disease
    Hassan, Y.
    Al-Ramahi, R. J.
    Aziz, N. A.
    Ghazali, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (09) : 571 - 576